|
Status |
Public on Feb 16, 2018 |
Title |
Gene expression data from RT112 following FGFR3 knock-down using FGFR3 siRNAs |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
To better understand the molecular mechanisms underlying altered-FGFR3 oncogenic activity in bladder carcinomas, we made use of RT112 cell lines, which were derived from a human bladder tumor and endogenously expressed the FGFR3-TACC3 fusion protein, the growth and transformation of these cell lines being dependent on activated-FGFR3 activity. We conducted a gene expression analysis using Affymetrix DNA arrays in this cell line treated or not with FGFR3 siRNAs.
|
|
|
Overall design |
RT112 cells were transfected or not with siRNA FGFR3. mRNA was extracted after 40h and gene expression analysis was assessed using the HG-U133 Plus 2.0 array (Affymetrix) array
|
|
|
Contributor(s) |
Dufour F, Plassard D, Chapeaublanc E, Bernard-Pierrot I, Gentien D |
Citation(s) |
29463565 |
|
Submission date |
Jul 22, 2016 |
Last update date |
May 18, 2018 |
Contact name |
Elodie chapeaublanc |
E-mail(s) |
elodie.chapeaublanc@pasteur.fr
|
Organization name |
Institut Curie
|
Department |
UMR 144
|
Lab |
Equipe Radvanyi
|
Street address |
26 rue d'ulm
|
City |
paris |
ZIP/Postal code |
75248 |
Country |
France |
|
|
Platforms (1) |
GPL19109 |
[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array [CDF: Brainarray HGU133Plus2_Hs_ENTREZG_v18] |
|
Samples (5)
|
|
This SubSeries is part of SuperSeries: |
|
Relations |
BioProject |
PRJNA330969 |